B lymphocytes as emerging mediators of insulin resistance
نویسندگان
چکیده
منابع مشابه
B lymphocytes as emerging mediators of insulin resistance
Obesity is associated with chronic inflammation of various tissues including visceral adipose tissue (VAT), which contributes to insulin resistance. T cells and macrophages infiltrate VAT in obesity and orchestrate this inflammation. Recently, we made the surprising discovery that B cells are important contributors to this process. Thus, some B cells and the antibodies they produce can promote ...
متن کاملB-1a Lymphocytes Attenuate Insulin Resistance
Obesity-associated insulin resistance, a common precursor of type 2 diabetes, is characterized by chronic inflammation of tissues, including visceral adipose tissue (VAT). Here we show that B-1a cells, a subpopulation of B lymphocytes, are novel and important regulators of this process. B-1a cells are reduced in frequency in obese high-fat diet (HFD)-fed mice, and EGFP interleukin-10 (IL-10) re...
متن کاملLipid mediators of insulin resistance.
Lipid abnormalities such as obesity, increased circulating free fatty acid levels, and excess intramyocellular lipid accumulation are frequently associated with insulin resistance. These observations have prompted investigators to speculate that the accumulation of lipids in tissues not suited for fat storage (e.g., skeletal muscle and liver) is an underlying component of insulin resistance and...
متن کاملRole of lipid-derived mediators in skeletal muscle insulin resistance.
Imbalance between nutritional intake and energy expenditure has been described to culminate in obesity, which predisposes to insulin resistance and type 2 diabetes mellitus. In such states of energy oversupply, excess amounts of lipids are available in tissues and circulation. Over the past years, an increasingly important role in development of skeletal muscle (SkM) insulin resistance has been...
متن کاملType B Insulin Resistance Syndrome as Anh.Pylori-Associated Autoimmune Disease
Type B insulin resistance syndrome (IRS) is characterised by production of autoantibodies against the insulin receptor (IR). These autoantibodies block insulin binding to the IR, resulting in severe insulin resistance. Some patients with this syndrome paradoxically exhibit episodic hypoglycaemia. Relatively burdensome therapies, including immunosuppression and plasmapheresis, are reportedly eff...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: International Journal of Obesity Supplements
سال: 2012
ISSN: 2046-2166,2046-2174
DOI: 10.1038/ijosup.2012.2